19 May 2013
Keywords: gilead, begins, enrolling, into, ph, ii, trial
Article | 30 March 2009
US drugmaker Gilead Sciences has begun enrolling patients in a Phase II trial of cicletanine HCl, an oral agent in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 2009
17 May 2013
© 2013 thepharmaletter.com